J.P. Laporte

931 total citations
32 papers, 574 citations indexed

About

J.P. Laporte is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, J.P. Laporte has authored 32 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 7 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in J.P. Laporte's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). J.P. Laporte is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). J.P. Laporte collaborates with scholars based in France, Belgium and Switzerland. J.P. Laporte's co-authors include A Najman, Luc Douay, Norbert Claude Gorin, F Isnard, L Fouillard, G Duhamel, Bruno Cazin, B Gallet, J Stachowiak and Manuel López and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

J.P. Laporte

30 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Laporte France 12 272 207 171 94 80 32 574
Marino Brunori Italy 16 416 1.5× 334 1.6× 90 0.5× 77 0.8× 41 0.5× 30 649
Taru Kuittinen Finland 18 468 1.7× 390 1.9× 157 0.9× 73 0.8× 48 0.6× 44 817
Jonathan P. Kerr United Kingdom 8 256 0.9× 205 1.0× 133 0.8× 173 1.8× 37 0.5× 11 818
Juichi Tanabe Japan 12 235 0.9× 62 0.3× 70 0.4× 74 0.8× 49 0.6× 25 417
J. L. Michaux Belgium 15 264 1.0× 81 0.4× 71 0.4× 149 1.6× 26 0.3× 31 559
S H Advani India 15 261 1.0× 162 0.8× 98 0.6× 141 1.5× 15 0.2× 50 616
E. Di Bona Italy 14 631 2.3× 320 1.5× 164 1.0× 175 1.9× 21 0.3× 21 973
Chikara Sakai Japan 12 100 0.4× 283 1.4× 423 2.5× 156 1.7× 27 0.3× 53 713
Ernesto de Meis Brazil 12 228 0.8× 94 0.5× 85 0.5× 48 0.5× 23 0.3× 21 484
Inmaculada Heras Spain 17 494 1.8× 281 1.4× 201 1.2× 112 1.2× 48 0.6× 44 962

Countries citing papers authored by J.P. Laporte

Since Specialization
Citations

This map shows the geographic impact of J.P. Laporte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Laporte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Laporte more than expected).

Fields of papers citing papers by J.P. Laporte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Laporte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Laporte. The network helps show where J.P. Laporte may publish in the future.

Co-authorship network of co-authors of J.P. Laporte

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Laporte. A scholar is included among the top collaborators of J.P. Laporte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Laporte. J.P. Laporte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masquelier, Julien, et al.. (2025). Validation of an LC-MS Method for Quantification of Mycotoxins and Characterization of Fungal Strains Occurring in Food and Feed. Chemosensors. 13(3). 106–106. 2 indexed citations
2.
3.
Laporte, J.P., et al.. (2002). Amélioration des ovins dans l'Ouémé et le Plateau en République du Bénin. Enjeux des croisements des ovins Djallonké avec les moutons du Sahel. Open Repository and Bibliography (University of Liège). 1 indexed citations
4.
Moreau, Philippe, D Fière, W. R. Bezwoda, et al.. (1997). Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.. Journal of Clinical Oncology. 15(2). 660–666. 34 indexed citations
5.
6.
7.
Belkacémi, Yazid, Mahmut Özşahin, B. Rio, et al.. (1995). Is veno-occlusive disease incidence influenced by the total-body irradiation technique?. PubMed. 171(12). 694–7. 10 indexed citations
8.
Laporte, J.P., Sylvie Lesage, M. Woler, et al.. (1994). Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high‐grade lymphoma. European Journal Of Haematology. 53(2). 123–124. 3 indexed citations
9.
Laporte, J.P., F Isnard, Sylvie Lesage, et al.. (1993). Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): a pilot study.. PubMed. 7(12). 2030–3. 26 indexed citations
10.
Isnard, Jean, et al.. (1993). [Indentation sign in the sylvian sulcus and the arterial origin of an acute subdural hematoma. Contribution of computerized tomography].. PubMed. 36(4). 269–74. 1 indexed citations
11.
Pérot, Christine, Marjan van den Akker, J.P. Laporte, et al.. (1993). Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide.. PubMed. 7(4). 509–15. 19 indexed citations
12.
Monconduit, M, Jean-François Ménard, J. L. Michaux, et al.. (1992). VAD or VMBCP in severe multiple myeloma. British Journal of Haematology. 80(2). 199–204. 16 indexed citations
13.
Gorin, Norbert Claude, J.P. Laporte, Myriam Labopin, et al.. (1991). Prophylactic heparin does not prevent liver veno‐occlusive disease following autologous bone marrow transplantation. European Journal Of Haematology. 47(5). 346–354. 62 indexed citations
14.
Fouillard, L, Norbert Claude Gorin, J.P. Laporte, et al.. (1991). Feasibility of autologous bone marrow transplantation for early consolidation of follicular non‐Hodgkin's lymphoma. European Journal Of Haematology. 46(5). 279–284. 29 indexed citations
15.
Laporte, J.P., L Fouillard, F Isnard, et al.. (1991). GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen. The Lancet. 338(8767). 601–602. 33 indexed citations
16.
Colombat, Philippe, Norbert Claude Gorin, C Binet, et al.. (1990). The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas.. Journal of Clinical Oncology. 8(4). 630–637. 67 indexed citations
17.
Laporte, J.P., Luc Douay, Manuel López, et al.. (1990). Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. British Journal of Haematology. 74(4). 445–451. 7 indexed citations
18.
Fouillard, L, Marjan van den Akker, J.P. Laporte, et al.. (1989). [Bone marrow autograft treated with mafosfamide in the acceleration phase in chronic myeloid leukemia. Inversion of the clinical development].. PubMed. 18(36). 1785–8. 2 indexed citations
19.
Cazin, Bruno, Norbert Claude Gorin, J.P. Laporte, et al.. (1986). Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer. 57(10). 2061–2069. 115 indexed citations
20.
Douay, Luc, Norbert Claude Gorin, Mercedes G. López, et al.. (1985). Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation.. PubMed. 45(1). 438–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marino Brunori Breakdown of academic impact, for papers by Taru Kuittinen Breakdown of academic impact, for papers by Jonathan P. Kerr Breakdown of academic impact, for papers by Juichi Tanabe Breakdown of academic impact, for papers by J. L. Michaux Breakdown of academic impact, for papers by S H Advani Breakdown of academic impact, for papers by E. Di Bona Breakdown of academic impact, for papers by Chikara Sakai Breakdown of academic impact, for papers by Ernesto de Meis Breakdown of academic impact, for papers by Inmaculada Heras
Rankless by CCL
2026